Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anteris Technologies Global Corp.AVR · Entity 5089 | Chief Financial Officer | September 11, 2026 | September 16, 2026 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Chief Financial Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anteris Technologies Global Corp.
Report date September 11, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.35 · Expires 2036-09-11 | Direct | 90,274 |
Reported balance
After 2026-09-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-11 · Grant · Acquired 90,274 · Balance 90,274 F1: On September 11, 2026, the Reporting Person was granted 90,274 stock options, which vest in approximately equal installments on September 11, 2027, September 11, 2028 and September 11, 2029, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 11, 2026, the Reporting Person was granted 90,274 stock options, which vest in approximately equal installments on September 11, 2027, September 11, 2028 and September 11, 2029, subject to the Reporting Person's continued service through each vesting date.
TACTILE SYSTEMS TECHNOLOGY INC
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,760 |
Reported balance
After 2023-03-01 transaction · row 1
1 source rowRow 1 · 2023-03-01 · Sale · Disposed 1,391 · Balance 48,760 F1: Consists of shares sold to cover taxes associated with the settlement of stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of shares sold to cover taxes associated with the settlement of stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ENTELLUS MEDICAL INC
Report date February 28, 2018 · Filed March 01, 2018
Section 16 reporting ended · disclosed 2018-03-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 1
1 source rowRow 1 · 2018-02-28 · Disposition to issuer · Disposed 12,865 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.74 · Expires 2026-06-04 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-02-28 · Disposition to issuer · Disposed 100,000 · Balance 0 F2: This option, which provided for vesting of 25% of the shares on May 23, 2017 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.01 · Expires 2027-01-04 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F3: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
F2: This option, which provided for vesting of 25% of the shares on May 23, 2017 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
F3: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 16, 2026 18:18 UTC | Anteris Technologies Global Corp. AVR · Entity 5089 | GrantEmployee Stock Option (right to buy) · Derivative | 90,274 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0001140361-26-036763 · form4.xml · derivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,274 Underlying: Common Stock · 90,274 shares Expires 2036-09-11 F1 · derivative.exercise_date: On September 11, 2026, the Reporting Person was granted 90,274 stock options, which vest in approximately equal installments on September 11, 2027, September 11, 2028 and September 11, 2029, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,391 | $14.10 | $19,613.10 |
DisclosureSEC source: 0001437749-23-005373 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,760 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:35 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 251 | $14.58 | $3,660.28 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 3 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,151 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 251 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.5813 to $14.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:35 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 3,801 | $15.36 | $58,398.56 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,402 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 3,801 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.345 to $15.375 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:35 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004977 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,203 F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 2,304 PSUs. Of those earned PSUs, one-third, or 768 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 1,536 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:35 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 176 | $20.64 | $3,633.06 |
DisclosureSEC source: 0001437749-22-005696 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,899 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019. F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,632 | $20.33 | $33,179.38 |
DisclosureSEC source: 0001437749-22-005171 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,075 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 01:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 624 | $19.85 | $12,383.28 |
DisclosureSEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,707 F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 29,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004754 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,331 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 20:17 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | Tax withholdingCommon Stock | 486 | $44.87 | $21,806.82 |
DisclosureSEC source: 0001437749-21-021567 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,205 F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:35 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 174 | $47.33 | $8,234.90 |
DisclosureSEC source: 0001437749-21-005438 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,691 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,429 | $50.91 | $72,747.25 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 3 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,865 F3 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | Tax withholdingCommon Stock | 826 | $54.12 | $44,703.12 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,294 F2 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of performance stock units. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 13,835 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · derivative · entry 4 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,835 Underlying: Common Stock · 13,835 shares Expires 2028-02-25 F4 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 5,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,120 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| September 02, 2020 Filed Sep 11, 2020 20:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | Tax withholdingCommon Stock | 486 | $36.94 | $17,952.84 |
DisclosureSEC source: 0001437749-20-019636 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,953 F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:26 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 175 | $48.64 | $8,512.00 |
DisclosureSEC source: 0001437749-20-004614 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,897 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:10 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 14,303 | $0.00 Strike: $50.41 | $0.00 |
DisclosureSEC source: 0001437749-20-004239 · rdgdoc.xml · derivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,303 Underlying: Common Stock · 14,303 shares Expires 2027-02-28 F2 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:10 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 13,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-004239 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,072 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:11 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | Tax withholdingCommon Stock | 513 | $54.12 | $27,763.56 |
DisclosureSEC source: 0001437749-20-003959 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,848 F2 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of PSUs. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:11 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 4,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003959 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,361 F1 · shares: On November 7, 2018, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019. As determined on February 26, 2020, based on actual performance for 2019, the reporting person earned 4,047 PSUs. Of those earned PSUs, one-third, or 1,349 PSUs, vested on February 26, 2020, and the remaining two-thirds, or 2,698 PSUs, are scheduled to vest on February 26, 2021. Read SEC document |
| September 02, 2019 Filed Sep 11, 2020 20:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | Tax withholdingCommon Stock | 486 | $50.44 | $24,513.84 |
DisclosureSEC source: 0001437749-20-019636 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,439 F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units. F2 · balance_after: The reporting person's Form 4 filed on February 28, 2020 inadvertently overstated the number of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of PSUs by 28 shares. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 22:26 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 4,175 | $0.00 Strike: $72.64 | $0.00 |
DisclosureSEC source: 0001437749-19-004229 · rdgdoc.xml · derivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,175 Underlying: Common Stock · 4,175 shares Expires 2026-03-04 F2 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 22:26 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 1,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-004229 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,314 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:34 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | PurchaseCommon Stock | 900 | $54.22 | $48,798.00 |
DisclosureSEC source: 0001437749-18-021208 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,662 Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 12,006 | $0.00 Strike: $62.99 | $0.00 |
DisclosureSEC source: 0001437749-18-020308 · rdgdoc.xml · derivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,006 Underlying: Common Stock · 12,006 shares Expires 2025-11-07 F2 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the employment start date, September 2, 2018. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 4,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-020308 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,762 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the employment start date, September 2, 2018. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 15:25 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 15,000 | $4.99 Strike: $19.01 | $74,850.00 |
DisclosureSEC source: 0001235802-18-000028 · primary_doc.xml · derivative · entry 3 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2027-01-04 F3 · derivative.exercise_date: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 15:25 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 100,000 | $6.26 Strike: $17.74 | $626,000.00 |
DisclosureSEC source: 0001235802-18-000028 · primary_doc.xml · derivative · entry 2 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2026-06-04 F2 · derivative.exercise_date: This option, which provided for vesting of 25% of the shares on May 23, 2017 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 15:25 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerCommon Stock, $0.001 par value | 12,865 | $24.00 | $308,760.00 |
DisclosureSEC source: 0001235802-18-000028 · primary_doc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 16:16 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | SaleCommon Stock, $0.001 par value | 735 | $24.01 | $17,647.35 |
DisclosureSEC source: 0001235802-18-000007 · primary_doc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,865 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 5,625 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. Read SEC document |
| May 08, 2017 Filed May 8, 2017 18:32 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | PurchaseCommon Stock, $0.001 par value | 6,100 | $12.21 | $74,475.51 |
DisclosureSEC source: 0001235802-17-000051 · primary_doc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,600 F1 · balance_after: Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:30 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | GrantNon-Statutory Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $19.01 | $0.00 |
DisclosureSEC source: 0001235802-17-000006 · primary_doc.xml · derivative · entry 2 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-01-04 F2 · derivative.exercise_date: This option vests with respect to 1/48th of the shares on February 4, 2017 and on each monthly anniversary of January 4, 2017 thereafter, subject to such Reporting Person's continued employment with Entellus Medical, Inc. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:30 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | GrantCommon Stock, $0.001 par value | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-17-000006 · primary_doc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · shares: These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. F1 · balance_after: These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.